ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,218Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1121

$1.49M Total Retail Price of All Prescriptions

Rank: 17 out of 1121

1,313 Patients Receiving at Least One Drug in Part D
41%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

43% of this provider’s 1,313 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 1,313 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 12,571 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
OMEPRAZOLE 786 397 1 6
LISINOPRIL 783 401 2 4
HYDROCODONE-ACETAMINOPHEN 721 328 S3 3 3
LEVOTHYROXINE SODIUM 696 414 4 2
ENDOCET 680 225 S2 5 107
NEXIUM 672 268 6 24
OXYCODONE HCL 590 132 S2 7 68
SIMVASTATIN 565 329 8 1
FUROSEMIDE 541 357 9 7
GABAPENTIN 532 230 10 13
POTASSIUM CHLORIDE 505 336 11 12
METOPROLOL TARTRATE 483 271 12 9
MORPHINE SULFATE ER 461 136 S2 13 87
METFORMIN HCL 460 264 14 8
AMLODIPINE BESYLATE 414 267 15 5
ATENOLOL 393 182 16 16
DICLOFENAC SODIUM 352 120 17 112
GLYBURIDE 301 148 R 18 51
WARFARIN SODIUM 293 199 19 11
PROAIR HFA 257 95 20 48
CITALOPRAM HBR 247 137 21 18
OXYCODONE HCL-ACETAMINOPHEN 246 75 S2 22 86
SPIRIVA 232 110 23 49
CRESTOR 223 115 24 28
METOCLOPRAMIDE HCL 213 75 25 120
PAROXETINE HCL 201 77 26 58
NABUMETONE 201 76 26 145
AZITHROMYCIN 193 111 28 44
CARISOPRODOL 191 27 R 29 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 190 47 30 31
POLYETHYLENE GLYCOL 3350 190 97 30 70
LOVASTATIN 186 123 32 26
TRIAMTERENE-HCTZ 176 102 33 38
ZOLPIDEM TARTRATE 165 55 34 19
MIRTAZAPINE 165 89 34 56
OXYCODONE-ACETAMINOPHEN 157 90 S2 36 122
LYRICA 157 52 36 76
SERTRALINE HCL 153 71 38 21
SINGULAIR 152 57 39 78
RANITIDINE HCL 152 77 39 33
FLUOXETINE HCL 148 66 41 60
FENTANYL 148 75 S2 41 100
LOSARTAN POTASSIUM 147 83 43 17
DEXILANT 146 44 44 136
MELOXICAM 145 73 45 22
ADVAIR DISKUS 135 79 46 64
OXYCONTIN 133 24 S2 47 165
PLAVIX 132 87 48 42
RAMIPRIL 130 110 49 74
SYMBICORT 129 56 50 148
HYDROCHLOROTHIAZIDE 128 79 51 10
METFORMIN HCL ER 126 70 52 47
CLOPIDOGREL 126 74 52 27
OPANA ER 126 16 S2 52 213
PROMETHAZINE HCL 124 40 R 55 67
PANTOPRAZOLE SODIUM 122 66 56 29
TRAZODONE HCL 121 67 57 40
TERAZOSIN HCL 120 83 58 130
ROPINIROLE HCL 118 62 59 91
QUETIAPINE FUMARATE 113 48 60 75
COMBIVENT 112 57 61 129
FLUTICASONE PROPIONATE 111 52 62 36
DIGOXIN 110 104 63 59
LANTUS 110 24 63 52
ATENOLOL-CHLORTHALIDONE 108 75 65 180
PRAMIPEXOLE DIHYDROCHLORIDE 107 54 66 158
RISPERIDONE 107 96 66 82
ALLOPURINOL 106 74 68 30
CARVEDILOL 105 64 69 20
TAMSULOSIN HCL 104 73 70 32
ATORVASTATIN CALCIUM 104 46 70 15
DIOVAN 101 65 72 45
GLIMEPIRIDE 99 65 73 34
PRAVASTATIN SODIUM 98 58 74 14
PREDNISONE 98 57 74 43
IPRATROPIUM-ALBUTEROL 96 83 76 160
BACLOFEN 86 14 77 131
AMITRIPTYLINE HCL 84 43 R 78 61
SEROQUEL XR 84 0 78 236
NAPROXEN 83 50 80 116
ISOSORBIDE MONONITRATE ER 81 49 81 62
CIPROFLOXACIN HCL 76 53 82 57
CYCLOBENZAPRINE HCL 74 11 R 83 83
SINGLE USE SWAB 74 40 83 302
INSULIN SYRINGE 74 42 83 77
CLONIDINE HCL 73 38 86 39
VENTOLIN HFA 73 13 86 92
METOPROLOL SUCCINATE 71 54 88 23
DOXYCYCLINE HYCLATE 71 34 88 103
CYMBALTA 71 15 88 50
METHOCARBAMOL 70 22 R 91 159
PREMARIN 70 45 R 91 96
PHENYTOIN SODIUM EXTENDED 69 27 93 135
HYDROXYZINE HCL 65 44 R 94 168
OLANZAPINE 65 52 94 181
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 27 94 108
LOSARTAN-HYDROCHLOROTHIAZIDE 65 40 94 46
VERAPAMIL ER 64 46 98 89
NITROSTAT 63 44 99 219
LIDODERM 61 45 100 229
TRAMADOL HCL 61 25 100 25
DONEPEZIL HCL 60 60 102 35
LEVEMIR 59 0 103 157
IBUPROFEN 58 12 104 110
NYSTATIN 57 40 105 147
SUCRALFATE 56 31 106 193
JANUVIA 56 41 106 81
AMOX TR-POTASSIUM CLAVULANATE 54 21 108 101
TIZANIDINE HCL 53 0 109 124
BENAZEPRIL HCL 52 39 110 41
NOVOLOG FLEXPEN 52 35 110 228
VENLAFAXINE HCL 51 30 112 201
FINASTERIDE 51 45 112 117
DIOVAN HCT 51 17 112 90
METOLAZONE 50 30 115 238
LAMOTRIGINE 50 24 115 187
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.